Vivimed Labs Limited (NSE:VIVIMEDLAB)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Speciality Chemicals Business		-	58.98M	112.21M	412.04M	535.09M
Pharma Business		1.16B	1.43B	1.77B	1.96B	8.08B
Total		1.16B	1.49B	1.88B	2.37B	8.61B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India		908.21M	1.41B	1.68B	2.31B	3.20B
Export		254.48M	84.32M	191.13M	58.20M	5.22B
Unallocated		-	-	-	7.17M	202.48M
Total		1.16B	1.49B	1.87B	2.37B	8.61B

Data Source: S&P Global Market Intelligence Last updated: Jul 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 4, 2026

Data Sources Report a data error